Risk stratification
& monitoring
Multi-condition
applications
Ease of
accessibility
Pain-free
solution
Chronic disease monitoring is complex, expensive and can be painful, meaning many people are without suitable monitoring and condition management.
In diabetes, for example, of the 600m+ living with the disease, less than half have been diagnosed and many are without an affordable, safe and pain-free way to monitor their condition.
These are alarming numbers, however we have a solution with benefits across chronic conditions and are developing our first application in diabetes and glucose monitoring.
*WHO Report ‘Monitoring noncommunicable disease commitments in Europe 2021: are we on track to reach targets 10 years after the Moscow Declaration and First United Nations High-Level Meeting?’ 08/12/2021, WHO/EURO:2021-4479-44242-62494
Every exhaled breath can give clues to our health and the status of chronic conditions.
Simply analysing breath allows patients to engage with their health and monitor ongoing conditions with ease and reduced costs equipment.
This will revolutionize condition monitoring and management in diabetes and beyond.
We are a collective of highly experienced professionals across MedTech, diabetes management, and breath analysis that are dedicated to solving big problems with simple solutions.
We are passionate about giving more people, the opportunity to manage their health without the worry of cost and discomfort.
At BOYDSense we believe in the potential of breath analysis to revolutionize health monitoring and management. Our first application will be in diabetes, but our future pipeline targets opportunities for detection and monitoring across a range of health and disease conditions including sepsis and fatty liver disease.
Our simple, cost effective and pain-free technology will offer significant benefits across a wide range of health and disease conditions.